SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-20-026818
Filing Date
2020-02-06
Accepted
2020-02-06 16:30:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 8-K d882573d8k.htm 425 31002
2 EX-99.1 d882573dex991.htm EX-99.1 17041
3 GRAPHIC g882573logo.jpg GRAPHIC 8147
  Complete submission text file 0001193125-20-026818.txt   61270
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filed by) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Subject) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36621 | Film No.: 20583082
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences